How did BBNX's Q4 2024 EPS outperform forecasts?

Beta Bionics' (BBNX) Q4 2024 EPS fell by -2.3, which underperformed forecasts. This indicates a challenging period for the company, especially considering the significant revenue growth reported during the same quarter. |code|Ticker|Name|Date|Estimate EPS|EPS Surprise|market_code| |---|---|---|---|---|---|---| |BBNX|BBNX.O|Beta Bionics|2024 Q4|-0.42|-2.3|185|